Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FPRR7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $164,083
Award facts
- Contract value 100% obligated
- $164,083.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $164,083.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda (pembrolizumab) 100 mg/4 mL vials. This firm fixed-price delivery order, issued on September 26, 2025, is set to be completed by October 20, 2025, with performance taking place at the contractor's Park Ridge location. The award represents a discrete delivery of this oncology medication to support Department of Defense healthcare requirements.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities. As a certified woman-owned small business operating since 2001, DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its IDC to deliver specialty medications, biologics, and other pharmaceutical products directly to Defense Department healthcare sites nationwide. No set-aside designation was applied to this particular delivery order.
Quick answers
Who was awarded contract SPE2DB25FPRR7?
SPE2DB25FPRR7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FPRR7 worth?
The government has obligated $164,083 on SPE2DB25FPRR7.
Is contract SPE2DB25FPRR7 an order under another contract?
Yes. SPE2DB25FPRR7 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPRR7 competed?
The extent of competition for SPE2DB25FPRR7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award